期刊文献+

变形链球菌表面蛋白spap A区真核表达质粒的构建及表达 被引量:4

Construction and expression of spap/A eukaryotic expression plasmid of Streptococcus mutans in mammalian cells
原文传递
导出
摘要 目的:构建变形链球菌表面蛋白A区(spap/A)真核表达质粒pVAX1-spap/A,并观察其在哺乳动物细胞COS-7中的表达。方法:通过基因重组技术,构建真核表达质粒pVAX1-spap/A。采用脂质体转染法,将其转染至COS-7细胞中,然后经免疫组化SABC法检测其在细胞中的表达。结果:真核表达质粒pVAX1-spap/A经酶切分析,证实携带spap/A片段。pVAX1-spap/A转染的细胞胞质呈褐色,pVAX1空质粒转染的细胞胞质中无着色。结论:成功构建真核表达质粒pVAX1-spap/A,所携带的基因序列正确,能够在真核细胞COS-7中正确表达目的蛋白,为下一步基因防龋疫苗的研究奠定了基础。 PURPOSE: The study is aimed to evaluate the expression of recombinant plasmid pVAXl-spap/A of surface protein antigen A of Streptococcus mutans in mammalian cells COS-7. METHODS: The eukaryotic plasmid carrying encoding gene of spap/A of Streptococcus mutans was constructed and the plasmid introduced into COS-7 cells by lipofeetamine reagent. The transient expressed protein was detected by immunochemistry technique in COS-7 cells. RESULTS: Positive expression was detected in plasma of the cells which were transfected with recombinant plasmid pVAX1-spap/A. The cells which were transfected with pVAX1 were negative. CONCLUSIONS: Spap/A can translate and express in COS-7 cells after transfected with recombinant plasmid pVAX1-spap/A. The expressed protein locates in the plasma and the protein is able to combine with anti-spap/A antibody. The expressed protein has the antigenicity and recombinant plasmid pVAXl-spap/A is a candidate vaccine.
出处 《上海口腔医学》 CAS CSCD 2009年第1期61-65,共5页 Shanghai Journal of Stomatology
基金 贵州省教育厅重点项目(黔教科2004119)~~
关键词 变形链球菌 表面蛋白 PVAX1 真核表达 Streptococcus mutans Surface protein antigen pVAX1 Eukaryotic expression
  • 相关文献

参考文献16

  • 1樊明文.关于免疫防龋[J].中华口腔医学杂志,2006,41(5):279-281. 被引量:11
  • 2刘建国.变链球菌表面蛋白P1和P1样蛋白分子结构研究概况[J].国外医学(口腔医学分册),1998,25(5):261-264. 被引量:2
  • 3Fan MW, Bian Z, Peng ZX, et al. A DNA vaccine encoding a cell surface protein antigen of Streptococcus mutans protects gnotobiotic rats from caries [J]. J Dent Res,2002,81(7):784-787.
  • 4Tuteja R.DNA vaccines: a ray of hope[J].Crit Rev Biochem Mol Biol,1999,34(1):1-24.
  • 5Guo JH, Jia R, Fan MW, et al. Construction and immunogenic characterization of a fusion anti-caries DNA vaccine against PAc and glucosyhransferase I of Streptoccus mutans [J]. J Dent Res, 2004,83(3):266-270.
  • 6Russel MW, Lehner T. Characterisation of antigens extracted from cells and culture fluids of Streptococcus mutaus serotype c [J]. Arch Oral Biol, 1978,23:7-15.
  • 7Lee SF, Progulske-Fox A, Bleiwis A.Molecular cloning and expression of a Streptococcus mutans major surface protein antigen, P1 (Ⅰ/Ⅱ), in Escherichia coli[J].Infect Immun,1988,56(8): 2114-2119.
  • 8Hajishengallis G, Nikolova E, Russell MW. Inhibition of Streptococcus mutans adherence to saliva-coated hydroxyapatite by human secretory immunoglobulin A (S-IgA) antibodies to cell surface protein antigen Ⅰ/Ⅱ: reversal by IgA1 protease cleavage [J]. Infect Immun, 1992,60:5057-5064.
  • 9Katz J, Harmon CC, Buckner GP, et al. Protective salivary immunoglobulin A responses against Streptococcus mutans infection after intranasal immunization with S.mutans antigen Ⅰ/Ⅱ coupled to the B subunit of cholera toxin [J].Infect Immum,1993, 61:1964-1971.
  • 10Ma Jk, Hunjan M, Smith R, et al. An investigation into the mechanism of protection by local passive immunization with monoclonal antibodies against Streptococcus mutans [J]. Infect Immun, 1990,58( 10):3407-3414 .

二级参考文献23

共引文献26

同被引文献64

引证文献4

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部